Barclays Capital Financials
| CAPD Etf | USD 19.37 0.00 0.00% |
Barclays |
The data published in Barclays Capital's official financial statements typically reflect Barclays Capital's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Barclays Capital's quantitative information. For example, before you start analyzing numbers published by Barclays accountants, it's essential to understand Barclays Capital's liquidity, profitability, and earnings quality within the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of Barclays Capital's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Barclays Capital's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Barclays Capital's management manipulating its earnings.
Barclays Capital Etf Summary
Barclays Capital competes with Humana, Amylyx Pharmaceuticals, Prime Medicine,, EnGene Holdings, and Zenas BioPharma,. The index seeks to provide a notional long exposure to the top four relatively undervalued U.S. equity sectors that also exhibit relatively strong price momentum. BARCLAYS ETN is traded on NYSEARCA Exchange in the United States.| Instrument | USA Etf View All |
| Exchange | NASDAQ Exchange |
| Region | Others |
| Investment Issuer | Others |
| Business Address | 2170 Century Park |
| Etf Family | Pharmaceuticals |
| Fund Category | Others |
| Portfolio Concentration | Others |
| Benchmark | Dow Jones Industrial |
| Website | canna-powder.com |
| Phone | NA |
| Currency | USD - US Dollar |
Barclays Capital Key Financial Ratios
| Return On Equity | -17.83 | |||
| Return On Asset | -3.48 | |||
| Beta | -0.22 | |||
| Z Score | 13.8 |
Barclays Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Barclays Capital's current stock value. Our valuation model uses many indicators to compare Barclays Capital value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Barclays Capital competition to find correlations between indicators driving Barclays Capital's intrinsic value. More Info.Barclays Capital is the top ETF in price to book as compared to similar ETFs. It is fourth largest ETF in beta as compared to similar ETFs . Comparative valuation analysis is a catch-all technique that is used if you cannot value Barclays Capital by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Barclays Capital Market Pulse
| Quote | 19.37 |
| Change(%) | 0.00 |
| Change | 0.00 |
| Open | 19.37 |
| Low | 19.37 |
| High | 19.37 |
| Volume | 0 |
| Exchange | NASDAQ |
About Barclays Capital Financials
What exactly are Barclays Capital Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Barclays Capital's income statement, its balance sheet, and the statement of cash flows. Potential Barclays Capital investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Barclays Capital investors may use each financial statement separately, they are all related. The changes in Barclays Capital's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Barclays Capital's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Barclays Capital December 30, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Barclays Capital help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Barclays Capital. We use our internally-developed statistical techniques to arrive at the intrinsic value of Barclays Capital based on widely used predictive technical indicators. In general, we focus on analyzing Barclays Etf price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Barclays Capital's daily price indicators and compare them against related drivers.
| Information Ratio | (0.15) |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
The market value of Barclays Capital is measured differently than its book value, which is the value of Barclays that is recorded on the company's balance sheet. Investors also form their own opinion of Barclays Capital's value that differs from its market value or its book value, called intrinsic value, which is Barclays Capital's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Barclays Capital's market value can be influenced by many factors that don't directly affect Barclays Capital's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Barclays Capital's value and its price as these two are different measures arrived at by different means. Investors typically determine if Barclays Capital is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Barclays Capital's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.